Drugs / 99mTc-rBitistatin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00808626 | Dec 2008 → Mar 2017 | venous thromboembolism | Temple University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-rBitistatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00808626 ↗ |
| Route | Intravenous | “Intravenous administration” NCT00808626 ↗ |